Daisy Woellner-Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daisy Woellner-Santos has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Américo Harry López-Yglesias
Indiana University School of Medicine, Department of Microbiology and Immunology, Indianapolis, IN, United States
2 shared publications - Ana Carolina Tahira
Laboratório de Ciclo Celular, Instituto Butantan, São Paulo 05503-900, SP, Brazil
2 shared publications - Mia C. Somenzi
Indiana University School of Medicine, Department of Microbiology and Immunology, Indianapolis, IN, United States
2 shared publications - Murilo Sena Amaral
Laboratório de Ciclo Celular, Instituto Butantan, Brazil
2 shared publications - Sergio Verjovski-Almeida
Laboratório de Ciclo Celular, Instituto Butantan, São Paulo 05503-900, SP, Brazil
2 shared publications - Abigail M. Bitters
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, USA
1 shared publication
Latest Publications
- Open Access
CD4⁺ T cell-intrinsic T-bet sustains protective CNS immunity and parasite control during Toxoplasma gondii infection
The transcription factor T-bet is widely regarded as the master regulator of type 1 immunity and is considered essential for host resistance to intracellular pathogens. Previous studies have demonstrated that global T-bet deficiency causes profound susceptibility to intracellular pathogens, including T . gondii . However, the specific cell-intrinsic requirement for T-bet within CD4⁺ T cells has remained unclear because T-bet regulates multiple innate and adaptive immune populations that contribute to protective immunity. Therefore, to define the cell-intrinsic role of T-bet in CD4⁺ T cells during infection, we utilized mice with conditional T-bet deletion in CD4⁺ T cells (CD4- Tbx21 −/− ) and found that CD4⁺ T cell-intrinsic T-bet was largely dispensable for acute parasite control and the generation of antigen-experienced IFN-γ-producing CD4⁺ T cells. However, although CD4- Tbx21 −/− mice controlled acute infection, our data reveal that as infection transitions to the chronic stage, CD4⁺ T cell-intrinsic T-bet becomes critical for sustaining cerebral immunity, promoting IFN-γ-dependent antimicrobial responses, and maintaining parasite control within the brain. Collectively, our findings establish that CD4⁺ T cell-intrinsic T-bet is required for sustaining protective CD4⁺ T cell responses within the infected CNS and promotes IFN-γ-dependent antiparasitic mechanisms that restrict tachyzoite persistence during the transition to chronic infection. Author Summary: Toxoplasma gondii is an intracellular parasite that can establish lifelong infection in the brain, where continuous immune responses are required to prevent parasite reactivation and disease. CD4⁺ T cells are central to this protection, and their effector functions are commonly associated with the transcription factor T-bet, a key regulator of type 1 immunity. Our previous work demonstrated that T-bet-dependent IFN-γ from innate lymphoid cells is essential for maintaining inflammatory dendritic cells during infection, yet CD4⁺ T cells can still produce IFN-γ even without T-bet. This raised the question of whether T-bet is truly required within CD4⁺ T cells to control T. gondii . To address this, we used mice lacking T-bet specifically in CD4⁺ T cells. Notably, these mice controlled early infection and generated IFN-γ-producing CD4⁺ T cells, demonstrating that T-bet is not strictly required to initiate these protective responses. However, as infection progressed, the absence of T-bet compromised the long-term maintenance of protective CD4⁺ T cell responses in the brain, resulting in impaired antimicrobial defenses and increased parasite persistence. Our findings reveal that the importance of T-bet in CD4⁺ T cells changes over the course of infection, becoming particularly critical for sustaining protective immunity in the central nervous system. These results provide new insight into how CD4⁺ T cells maintain control of persistent intracellular pathogens.
Open AccessCD4⁺ T cell-intrinsic T-bet sustains protective CNS immunity and parasite control during Toxoplasma gondii infection
The transcription factor T-bet is widely regarded as the master regulator of type 1 immunity and is considered essential for host resistance to intracellular pathogens. Previous studies have demonstrated that global T-bet deficiency causes profound susceptibility to intracellular pathogens, including T . gondii . However, the specific cell-intrinsic requirement for T-bet within CD4⁺ T cells has remained unclear because T-bet regulates multiple innate and adaptive immune populations that contribute to protective immunity. Therefore, to define the cell-intrinsic role of T-bet in CD4⁺ T cells during infection, we utilized mice with conditional T-bet deletion in CD4⁺ T cells (CD4- Tbx21 −/− ) and found that CD4⁺ T cell-intrinsic T-bet was largely dispensable for acute parasite control and the generation of antigen-experienced IFN-γ-producing CD4⁺ T cells. However, although CD4- Tbx21 −/− mice controlled acute infection, our data reveal that as infection transitions to the chronic stage, CD4⁺ T cell-intrinsic T-bet becomes critical for sustaining cerebral immunity, promoting IFN-γ-dependent antimicrobial responses, and maintaining parasite control within the brain. Collectively, our findings establish that CD4⁺ T cell-intrinsic T-bet is required for sustaining protective CD4⁺ T cell responses within the infected CNS and promotes IFN-γ-dependent antiparasitic mechanisms that restrict tachyzoite persistence during the transition to chronic infection. Author Summary: Toxoplasma gondii is an intracellular parasite that can establish lifelong infection in the brain, where continuous immune responses are required to prevent parasite reactivation and disease. CD4⁺ T cells are central to this protection, and their effector functions are commonly associated with the transcription factor T-bet, a key regulator of type 1 immunity. Our previous work demonstrated that T-bet-dependent IFN-γ from innate lymphoid cells is essential for maintaining inflammatory dendritic cells during infection, yet CD4⁺ T cells can still produce IFN-γ even without T-bet. This raised the question of whether T-bet is truly required within CD4⁺ T cells to control T. gondii . To address this, we used mice lacking T-bet specifically in CD4⁺ T cells. Notably, these mice controlled early infection and generated IFN-γ-producing CD4⁺ T cells, demonstrating that T-bet is not strictly required to initiate these protective responses. However, as infection progressed, the absence of T-bet compromised the long-term maintenance of protective CD4⁺ T cell responses in the brain, resulting in impaired antimicrobial defenses and increased parasite persistence. Our findings reveal that the importance of T-bet in CD4⁺ T cells changes over the course of infection, becoming particularly critical for sustaining protective immunity in the central nervous system. These results provide new insight into how CD4⁺ T cells maintain control of persistent intracellular pathogens.
- Open Access
- 25 July 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1) , 318
IFN-γ protects the human blood-brain barrier from Toxoplasma gondii-mediated dysfunction via CCL2 suppression
- 25 July 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1) , 318
Open AccessIFN-γ protects the human blood-brain barrier from Toxoplasma gondii-mediated dysfunction via CCL2 suppression
- Open Access
- 4 January 2024
- Published by Springer Nature in npj Vaccines
- Vol. 9 (1) , 1-19
Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques
Schistosomiasis, a challenging neglected tropical disease, affects millions of people worldwide. Developing a prophylactic vaccine againstSchistosoma mansonihas been hindered by the parasite’s biological complexity. In this study, we utilized the innovative phage-display immunoprecipitation followed by a sequencing approach (PhIP-Seq) to screen the immune response of 10 infected rhesus macaques during self-cure and challenge-resistant phases, identifying vaccine candidates. Our high-throughputS. mansonisynthetic DNA phage-display library encoded 99.6% of 119,747 58-mer peptides, providing comprehensive coverage of the parasite’s proteome. Library screening with rhesus macaques’ antibodies, from the early phase of establishment of parasite infection, identified significantly enriched epitopes of parasite extracellular proteins known to be expressed in the digestive tract, shifting towards intracellular proteins during the late phase of parasite clearance. Immunization of mice with a selected pool of PhIP-Seq-enriched phage-displayed peptides from MEG proteins, cathepsins B, and asparaginyl endopeptidase significantly reduced worm burden in a vaccination assay. These findings enhance our understanding of parasite-host immune responses and provide promising prospects for developing an effective schistosomiasis vaccine.
- 4 January 2024
- Published by Springer Nature in npj Vaccines
- Vol. 9 (1) , 1-19
Open AccessSchistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques
Schistosomiasis, a challenging neglected tropical disease, affects millions of people worldwide. Developing a prophylactic vaccine againstSchistosoma mansonihas been hindered by the parasite’s biological complexity. In this study, we utilized the innovative phage-display immunoprecipitation followed by a sequencing approach (PhIP-Seq) to screen the immune response of 10 infected rhesus macaques during self-cure and challenge-resistant phases, identifying vaccine candidates. Our high-throughputS. mansonisynthetic DNA phage-display library encoded 99.6% of 119,747 58-mer peptides, providing comprehensive coverage of the parasite’s proteome. Library screening with rhesus macaques’ antibodies, from the early phase of establishment of parasite infection, identified significantly enriched epitopes of parasite extracellular proteins known to be expressed in the digestive tract, shifting towards intracellular proteins during the late phase of parasite clearance. Immunization of mice with a selected pool of PhIP-Seq-enriched phage-displayed peptides from MEG proteins, cathepsins B, and asparaginyl endopeptidase significantly reduced worm burden in a vaccination assay. These findings enhance our understanding of parasite-host immune responses and provide promising prospects for developing an effective schistosomiasis vaccine.
- Open Access
The human developing cerebral cortex is characterized by an increased de novo expression of lncRNAs in excitatory neurons
Background: Outstanding human cognitive abilities are computed in the cerebral cortex, a mammalian-specific brain region and the place of massive biological innovation. Long noncoding RNAs (lncRNAs) have emerged as gene regulatory elements with higher evolutionary turnover than mRNAs. The many lncRNAs identified in neural tissues make them candidates for molecular sources of cerebral cortex evolution and disease. Here, we characterized the genomic and cellular shifts that occurred during the evolution of the lncRNA repertoire expressed in the developing cerebral cortex of humans and explored their role in the evolution of this brain region. Results: Using systems biology approaches and comparative transcriptomics, we comprehensively annotated the cortical transcriptomes of humans, macaques, mice, and chickens and classified human cortical lncRNAs into evolutionary groups as a function of their predicted minimal ages. LncRNA evolutionary groups showed differences in expression levels, splicing efficiencies, transposable element contents, genomic distributions, and transcription factor binding to their promoters. Furthermore, older lncRNAs showed preferential expression in germinative zones, outer radial glial cells, and cortical inhibitory neurons. In comparison, younger lncRNAs showed preferential expression in cortical excitatory neurons, belonged to human-specific gene coexpression modules, and were dysregulated in autism spectrum disorder. Conclusions: These results suggest a shift in the roles of cortical lncRNAs over evolution, highlighting the antique lncRNAs as a source of molecular evolution of conserved developmental programs; conversely, the de novo expression of primate and human-specific lncRNAs are sources of molecular evolution and dysfunction of cortical excitatory neurons.
Open AccessThe human developing cerebral cortex is characterized by an increased de novo expression of lncRNAs in excitatory neurons
Background: Outstanding human cognitive abilities are computed in the cerebral cortex, a mammalian-specific brain region and the place of massive biological innovation. Long noncoding RNAs (lncRNAs) have emerged as gene regulatory elements with higher evolutionary turnover than mRNAs. The many lncRNAs identified in neural tissues make them candidates for molecular sources of cerebral cortex evolution and disease. Here, we characterized the genomic and cellular shifts that occurred during the evolution of the lncRNA repertoire expressed in the developing cerebral cortex of humans and explored their role in the evolution of this brain region. Results: Using systems biology approaches and comparative transcriptomics, we comprehensively annotated the cortical transcriptomes of humans, macaques, mice, and chickens and classified human cortical lncRNAs into evolutionary groups as a function of their predicted minimal ages. LncRNA evolutionary groups showed differences in expression levels, splicing efficiencies, transposable element contents, genomic distributions, and transcription factor binding to their promoters. Furthermore, older lncRNAs showed preferential expression in germinative zones, outer radial glial cells, and cortical inhibitory neurons. In comparison, younger lncRNAs showed preferential expression in cortical excitatory neurons, belonged to human-specific gene coexpression modules, and were dysregulated in autism spectrum disorder. Conclusions: These results suggest a shift in the roles of cortical lncRNAs over evolution, highlighting the antique lncRNAs as a source of molecular evolution of conserved developmental programs; conversely, the de novo expression of primate and human-specific lncRNAs are sources of molecular evolution and dysfunction of cortical excitatory neurons.